Citadel Advisors’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$819K Buy
198,400
+42,800
+28% +$189K ﹤0.01% 8696
2026
Q1
$562K Buy
155,600
+50,600
+48% +$175K ﹤0.01% 9024
2025
Q4
$358K Sell
105,000
-27,400
-21% -$133K ﹤0.01% 9766
2025
Q3
$899K Sell
132,400
-121,400
-48% -$1M ﹤0.01% 7762
2025
Q2
$3.46M Buy
253,800
+197,100
+348% +$1.86M ﹤0.01% 4729
2025
Q1
$308K Buy
56,700
+25,500
+82% +$145K ﹤0.01% 9514
2024
Q4
$154K Sell
31,200
-5,100
-14% -$26.7K ﹤0.01% 10830
2024
Q3
$190K Sell
36,300
-23,200
-39% -$134K ﹤0.01% 10229
2024
Q2
$408K Sell
59,500
-43,200
-42% -$395K ﹤0.01% 8472
2024
Q1
$1.06M Buy
102,700
+62,500
+155% +$462K ﹤0.01% 6806
2023
Q4
$333K Buy
40,200
+16,800
+72% +$121K ﹤0.01% 8960
2023
Q3
$146K Buy
23,400
+8,400
+56% +$36.4K ﹤0.01% 10401
2023
Q2
$65.3K Buy
15,000
+10,800
+257% +$24K ﹤0.01% 11489
2023
Q1
$7.14K Sell
4,200
-16,400
-80% -$29K ﹤0.01% 13754
2022
Q4
$40K Sell
20,600
-16,400
-44% -$36.8K ﹤0.01% 12418
2022
Q3
$73K Buy
37,000
+3,300
+10% +$7.87K ﹤0.01% 11344
2022
Q2
$69K Sell
33,700
-15,400
-31% -$38.3K ﹤0.01% 11716
2022
Q1
$173K Sell
49,100
-2,800
-5% -$9.94K ﹤0.01% 11690
2021
Q4
$201K Sell
51,900
-64,400
-55% -$304K ﹤0.01% 11844
2021
Q3
$722K Sell
116,300
-50,500
-30% -$431K ﹤0.01% 8983
2021
Q2
$1.97M Sell
166,800
-60,400
-27% -$695K ﹤0.01% 6668
2021
Q1
$3.59M Buy
+227,200
New +$4.09M ﹤0.01% 5019

Other funds holding LFMD

Citadel Advisors's LFMD Position: Q2 2026 in Review

Citadel Advisors opened a new position in LifeMD (LFMD) in Q2 2026: 263,471 shares worth $1.09M. The stake represents ﹤0.01% of the portfolio and ranks #7996 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in LFMD as recently as Q4 2025.

Citadel Advisors first reported a position in LFMD in Q1 2021 and has held it in 20 quarters since. The position peaked at $4.47M in Q3 2025. 115 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Citadel Advisors held 263,471 shares of LifeMD worth $1.09M as of Q2 2026.
  • LifeMD was a new Citadel Advisors position in Q2 2026.
  • LifeMD made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7996 holding.
  • Citadel Advisors first reported a position in LifeMD in Q1 2021 and has held it in 20 quarters since.
  • Citadel Advisors's LifeMD position peaked at $4.47M in Q3 2025.
  • 115 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.